Related Experiment Videos
Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes
1Baylor College of Medicine, The Methodist Hospital, Houston, TX 77030, USA.
Diabetes, Obesity & Metabolism
|February 28, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Will the next generation of basal insulins offer clinical advantages?
Diabetes, obesity & metabolism·2013
Treat-to-target trials: uses, interpretation and review of concepts.
Diabetes, obesity & metabolism·2013
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.
Diabetes, obesity & metabolism·2013
Methods to enhance delivery of prandial insulin and basal-prandial insulin.
Diabetes, obesity & metabolism·2013
Non-Invasive Fibrosis Testing in Adults With Obesity and MASLD: A Systematic Review and Meta-Analysis.
Diabetes, obesity & metabolism·2026
Layered Effects of LDL-C Burden and Variability on Cardiovascular Events and Mortality in Type 2 Diabetes: A Nationwide Cohort Study.
Diabetes, obesity & metabolism·2026
KCNH6 Controls Hepatic Lipid Metabolism by Regulating Mitochondrial Function Associated With IKKβ/NF-κB Activation.
Diabetes, obesity & metabolism·2026
Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy.
Diabetes, obesity & metabolism·2026
Liver Fibrosis and IRS1 rs2972146 Are Associated With Weight Loss Response After Metabolic Bariatric Surgery.
Diabetes, obesity & metabolism·2026
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
Missouri medicine·2026
Dose-related propofol resistance in COVID-19 patients: Altered drug plasma levels, mechanistic insights from neuronal-derived extracellular vesicles and miRNA analysis.
British journal of clinical pharmacology·2026
Short-Term Efficacy of Tegoprazan Compared With Esomeprazole in Patients With Non-Erosive Reflux Disease and Nocturnal Heartburn Symptoms: A Double-Blind, Randomized Controlled Trial.
The Korean journal of helicobacter and upper gastrointestinal research·2026